The New England journal of medicine, 2019-01, Vol.380 (4), p.315-324
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- Ist Teil von
- The New England journal of medicine, 2019-01, Vol.380 (4), p.315-324
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In a randomized, delayed-start trial of levodopa in Parkinson’s disease, with one group receiving the drug for 80 weeks and the other starting at 40 weeks, the difference between the groups in the progression of symptoms was not significant.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1809983Titel-ID: cdi_proquest_miscellaneous_2179430598
- Format
- –
- Schlagworte
- Activities of daily living, Aged, Antiparkinson Agents - administration & dosage, Antiparkinson Agents - adverse effects, Carbidopa - administration & dosage, Carbidopa - adverse effects, Clinical trials, Disease Progression, Dopamine, Double-Blind Method, Drug Administration Schedule, Drug dosages, Drug Therapy, Combination, Dyskinesia, Evidence-based medicine, Female, Grants, Humans, Levodopa, Levodopa - administration & dosage, Levodopa - adverse effects, Male, Medical imaging, Medical research, Middle Aged, Parkinson Disease - drug therapy, Parkinson's disease, Patients, R&D, Research & development, Time-to-Treatment